The Way on FDA, published by Thompson Hine LLP, focuses on legal and regulatory developments related to the U.S. Food and Drug Administration (FDA). The blog covers topics such as FDA import requirements, drug manufacturing technologies including distributed and point-of-care manufacturing, regulatory guidance on medical device submissions like 510(k)s, and FDA policies on emerging products such as vaping and cannabidiol (CBD). It also addresses legislative interactions with FDA regulations and enforcement, providing updates on rules, guidance documents, and industry feedback opportunities. The content is relevant for stakeholders navigating FDA compliance, regulatory strategy, and policy changes affecting pharmaceuticals, medical devices, tobacco products, and related sectors.